Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity.
Lind J, Aksoy O, Prchal-Murphy M, Fan F, Fulciniti M, Stoiber D, Bakiri L, Wagner EF, Zwickl-Traxler E, Sattler M, Kollmann K, Vallet S, Podar K.
Lind J, et al. Among authors: aksoy o.
Blood Cancer J. 2024 Aug 19;14(1):138. doi: 10.1038/s41408-024-01117-4.
Blood Cancer J. 2024.
PMID: 39160158
Free PMC article.